Menthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function

Similar documents
Are Menthol Cigarettes a Starter Product for Youth?

Menthol Cigarette Report

Clinical Effects. Jane Y. Lewis, Ph.D. Senior Vice President, Health & Analytical Sciences Altria Client Services

Menthol cigarettes are a public health problem

STATE OF NEW JERSEY. ASSEMBLY, No th LEGISLATURE. Sponsored by: Assemblyman HERB CONAWAY, JR. District 7 (Burlington)

TOBACCO USE AMONG AFRICAN AMERICANS

Comparisons Between Adult Menthol and Non-Menthol Smokers Total Exposure Study. Mohamadi Sarkar, M.Pharm., Ph.D Altria Client Services

A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE

Nebraska Youth Tobacco Survey 2015/2017

Supplementary Online Content

Menthol and the Tobacco Products Scientific Advisory Committee

Menthol cigarettes and the public health standard: a systematic review

Re: Docket No. FDA-2013-N-0521, Menthol in Cigarettes, Tobacco Products; Request for Comments

Nicotine dependence and intentions to quit among a communitybased sample of African American menthol and non-menthol smokers in Los Angeles

Real-World Data for Enhancement of a National Smoking Cessation Intervention

Tobacco-related risk perceptions in the regulation of tobacco products at the FDA Center for Tobacco Products

The Latest on Vaping Among U.S. Teens

Predicting the population health effects of changing tobacco exposures: Statistical models for regulatory compliance

Cigarette Packaging in Ireland: The Plain Future.

Cessation and Cessation Measures

Smoking Status and Body Mass Index in the United States:

Changes in Number of Cigarettes Smoked per Day: Cross-Sectional and Birth Cohort Analyses Using NHIS

Perceived Effectiveness of Pictorial versus Textual Health Warning Labels on Waterpipe Tobacco Packages (Tumbac packages)

Sample Evaluation Plan. Indicator 4.1.1

Modeling of E-cigarette Use. David Levy, PhD Georgetown University

Electronic Nicotine Delivery Systems: Patterns of Use and Disparities

Background and Analysis Objectives Methods and Approach

A REPORT ON THE INCIDENCE AND PREVALENCE OF YOUTH TOBACCO USE IN DELAWARE :

FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality

How to Regulate E-Cigarettes? Are we asking the right questions?

E-Cigarette Use Transitions: a Case Study from Waves 1 & 2 of the PATH Study

Running head: SENSORY PERCEPTIONS OF NICOTINE REPLACEMENT THERAPY BETWEEN MENTHOL AND NONMENTHOL CIGARETTE SMOKERS

Menthol and Flavour Ban Evaluation Results

Cessation Outcomes Among Treatment- Seeking Menthol and Nonmenthol Smokers

Declaration of Conflict of Interest. No potential conflict of interest to disclose with regard to the topics of this presentations.

Hookah s New Popularity Among US College Students. Libby N Brockman MCH Research Festival

The Modified Risk Products. or Protectionism?

The Family Smoking Prevention and Tobacco Control Act s Grant of Authority to the FDA and the Impact on the Grower

FDA should prohibit of use of flavors in deemed tobacco products as part of the current rulemaking

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

Smoking Cessation: A readily modifiable risk factor

Communicating the Risk of Nicotine Delivery Products

Reducing Tobacco Use and Secondhand Smoke Exposure: Interventions to Increase the Unit Price for Tobacco Products

Research Study: Court-Ordered Corrections of Tobacco Industry Racketeering PRELIMINARY REPORT Background Methods Results Conclusions

Varenicline and cardiovascular and neuropsychiatric events: Do Benefits outweigh risks?

Exploring five common claims about e-cigarette use. Lion Shahab, PhD University College

Substance Use Among Potential Kidney Transplant Candidates and its Impact on Access to Kidney Transplantation: A Canadian Cohort Study

Are Canadian Smokers Ready for Plain Packaging? Findings from the ITC Four Country Survey,

Peter G. Shields, MD Tobacco Products Scientific Advisory Committee (TPSAC) August 16, 2013

BRIEF REPORT OPTIMISTIC BIAS IN ADOLESCENT AND ADULT SMOKERS AND NONSMOKERS

Menthol and Cigarettes

Veterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned

Ordinance amending the Health Code to prohibit tobacco retailers from selling flavored

Mitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association

The Burden of Tobacco, Tobacco Control, and Advocacy: Policy Strategies for Oral Health. Robert McMillen, PhD

Advancing Health Equity in Lung Cancer Outcomes

Comprehensive Tobacco Control Programs: Economic Review. Page 1 of 26. Study Info Intervention Characteristics Population Characteristics

Data Highlights from the 2013 Hawai'i Youth Tobacco Survey (YTS) and Comparisons with Prior Years

Present value cost-savings to Medicaid over 25 years

Electronic Cigarettes and the Medical Society

Perceived relative harm of e cigarettes and attitudes towards their availability, advertising and use: A longitudinal survey

Key findings from a national survey of 1,000 registered voters, conducted February 2-5, Project # 15054

National Lung Screening Trial Results

Supplementary Material

Karen Nieves-Lugo, PhD George Washington University

Setting The setting was a hospital and the community. The economic analysis was carried out in the USA.

Effects of smoking and smoking cessation on productivity in China

Recent Findings from the ITC Project on the Effectiveness of Health Warnings in the Asia Pacific Region

The cost-effectiveness of raising the legal smoking age in California Ahmad S

Tobacco use among african-americans in Minnesota :

/msdcenter. msdcenter. Tomorrow in Austin and via Livestream: msdcenter.org

Supplementary Appendix

GATS Philippines Global Adult Tobacco Survey: Executive Summary 2015

FDA Center for Tobacco Products: Tobacco Research and the Population Assessment of Tobacco and Health (PATH) Study

Problem Which option Additional option Additional comments definition Yes No change No further observations.

Final Frequencies (n=1,000) NATIONAL HEALTH SURVEY The Mellman Group & Public Opinion Strategies April 11, 2017

Retention in HIV care predicts subsequent retention and predicts survival well after the first year of care: a national study of US Veterans

REPORT OF THE BOARD OF TRUSTEES. Subject: Annual Update on Activities and Progress in Tobacco Control: March 2017 through February 2018

Non-Industry Voices on Tobacco Harm Reduction and Vaping Products

Appendix: Supplementary tables [posted as supplied by author]

Marijuana and tobacco use among young adults in Canada: are they smoking what we think they are smoking?

Brand descriptors, health policy, packaging, perceptions of risk, smoking, tobacco.

Tobacco Control Policy and Legislation Antero Heloma, MD, PhD Principal Medical Adviser. 20/03/2012 Presentation name / Author 1

Pharmacotherapy for Tobacco Dependence Treatment

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database

CHRONIC DISEASE PREVALENCE AMONG ADULTS IN OHIO

diagnosis and initial treatment at one of the 27 collaborating CCSS institutions;

Family Smoking Prevention and Tobacco Control Act. Comments regarding crop protection agents

2017Adult Male Preventive Health Guidelines

Black History Month Make Smoking History Toolkit #MentholisNotYourFriend Instagram Contest February 2018

The Assault on Intellectual Property: The Australian Plain Packaging Experience. Sinclair Davidson RMIT University

Supplementary Online Content

THE IMPORTANCE OF POINT OF SALE

Electronic Cigarette Use and Respiratory Symptoms in Chinese Adolescents in Hong Kong. Title. Wang, MP; Ho, DSY; Leung, LT; Lam, TH

Social and Behavioral Sciences for Tobacco Use

Trends in electronic cigarette use in England

Supplementary Online Content

FREQUENTLY ASKED QUESTIONS MINIMAL DATA SET (MDS)

Psychosocial Correlates of Youth Smoking in Mississippi

Transcription:

Center for Regulatory Effectiveness (CRE) assessment of the following research report: Menthol Cigarettes, Smoking Cessation, Atherosclerosis and Pulmonary Function By: Mark J. Pletcher, MD, MPH; Benjamin J. Hulley; Thomas Houston, MD; Catarina I. Kiefe, MD, PhD;Neal Benowitz, MD; Stephen Sidney, MD, MPH (2006) August 20 1

Reference: Research Report: Menthol Cigarettes, Smoking Cessation, Atherosclerosis, and Pulmonary Function Arch Intern Med. 2006;166:191-1922, by Dr. Mark J. Pletcher, et al. Background On June 22, 2009, President Obama signed into law the Family Smoking Prevention and Tobacco Control Act, which gives the Food and Drug Administration the power to further regulate the tobacco industry. One element of the law imposes new warnings and labels on tobacco packaging, with the goal of discouraging minors and young adults from smoking. The bill bans flavored cigarettes, including cloves, cinnamon, candy, and fruit flavors, with a special exception for menthol cigarettes. There is a need to investigate possible health hazards of smoking menthol cigarettes as well as cessation (quitting) efforts. The Tobacco Products Scientific Advisory Committee (TPSAC) provisioned under the bill is to submit a recommendation on menthol cigarettes to the United States Secretary of Health and Human Services no later than March 23, 2012. The intent of this CRE assessment is to consider the merits and shortfalls of the study as well as present the reader with topics for further discussion and investigation. The report at reference was identified for review and public discussion due to its focus on young adults mentholated cigarette use in relation to race (African Americans versus European Americans), smoking cessation behavior, and tobacco related morbidity (coronary calcification and change in pulmonary function). The study used 198 to 2000 data from the Coronary Artery Risk Development in Young Adults (CARDIA) Study. The CARDIA Study is a longitudinal study of risk factors for coronary artery disease in 11 African American and European American women and men aged 18 to 30 years and healthy at the time of enrollment in 198. Participants underwent a baseline examination and then follow-up examinations at years 2,,,, and 1, with 4% retention of the surviving cohort at year 1. For this investigation, the researchers identified CARDIA smokers and measured associations between menthol/nonmenthol exposure and smoking cessation behaviors during follow-up, the prevalence of coronary calcification in 2000, and changes in pulmonary function test results between 198 and 199. The following timeline generally illustrates the time points when variables were measured. (198) 2 (198) (199) Menthol smoking status Smoking cessation behaviors Not currently smoking Recent quit attempt Cessation if recent quit attempt Sustained smoking cessation X X X X Documented relapse X Tobacco related coronary calcification Pulmonary function X X 1 X 2

The researchers presented the following primary results: African American smokers were statistically significantly more likely to be menthol cigarette users than European American smokers (89% versus 29%, p < 0.001); Menthol smokers had statistically nonsignificant lower cessation and recent quit attempt rates and a statistically significantly higher risk of relapse than nonmenthol smokers (odds ratios [9% confidence interval] for cessation, recent quit attempt, and risk of relapse, in order, were 0.1[0.49, 1.02], 0.[0.6, 1.06], 1.89[1.1, 3.0]), after adjusting for ethnicity, demographics, and social factors. There were no statistically significant differences from menthol in tobacco related coronary function or -year pulmonary function decline, after for ethnicity, demographics, and social factors. The researchers therefore concluded that Menthol and nonmenthol cigarettes seem to be equally harmful per cigarette smoked in terms of atherosclerosis and pulmonary function decline, but menthol cigarettes may be harder to quit smoking. The CRE conducted a limited assessment which comprised a review of the report. Summary of Findings and Issues 1. Is the measurement of menthol exposure accurate and adequate? The independent variable, menthol exposure, was defined as cumulative exposure to menthol packyears and nonmenthol pack years using information on current smoking, number of cigarettes smoked per day, menthol preference, and past years of smoking at baseline, assuming that participants smoked only menthol or nonmenthol cigarettes at any one time. This assumption needs to be justified. Intervals between two measurement points were two to five years; switch from menthol to nonmenthol cigarettes or vice versa is likely to happen. It was reported that younger smokers were highly likely to switch to menthol cigarettes (Sidney et al 1989). Therefore, this assumption potentially underestimated menthol pack years. In addition, menthol exposure was measured as a binary variable at every time point, as well as two independent numeric variables (menthol pack years and nonmenthol pack years). The study only explicitly described how the two numeric variables were defined and how they were analyzed in the logistic regression models with coronary calcification and change in pulmonary function as outcomes. There were no such descriptions regarding how menthol exposure was defined in logistic regression models with smoking cessation behavior variables as outcomes. From the title of Table 2, the reader learnt that only menthol preference at baseline was assessed in terms of its relationship with smoking cessation behavior variables. An advanced appropriate way is to treat it as timedependent binary variable. 2. Problems with measurements of smoking cessation behaviors. There were five measurements of smoking cessation behaviors. The definitions of those measurements were overlapped and confused. For example, the measurement cessation if recent quit attempt is a sub-group of recent quit attempt; it would be more efficient to define the two separate 3

binary variables as one categorical variable with 3-levels: no recent quit attempt/recent quit attempt but no cessation/recent quit attempt and cessation. The definitions of sustained smoking cessation and documented relapse in this study are confusing. By the definitions of this study, those two opposite behaviors (the former is considered as a positive smoking cessation behavior while the latter a negative behavior) can be obtained for one case. Suppose a subject had longitudinal smoking behaviors recorded as the following: (198) 2 (198) (199) 1 smoking status at the time (1=yes,0=no) 1 0 0 0 0 1 Based on the definition of sustained smoking cessation (no current smoking the past 2 times they were examined), the case was in sustained smoking cessation at time 1992, 199, and 2000. Based on the definition of documented relapse (baseline smokers who reported no current smoking at a subsequent examination and then current smoking the final time they were examined), the case was also in documented relapse at time 2000. In addition, the definition of documented relapse didn t capture all the patterns for relapse over the time course of this study. For example, if a case with behavioral pattern as the following: (198) 2 (198) (199) 1 smoking status at the time (1=yes,0=no) 1 0 0 1 1 0 should it be accounted as a documented relapse? However, by the definition of relapse in this study, it s a non relapse case. 3. Was the logistic regression with 1 observation per participant adequate for sustained smoking cessation? Based on the definition of sustained smoking cessation (no current smoking the past 2 times they were examined), a case should have as many as 4 measurements for this variable at times 1990, 1992, 199, and 2000. But the researcher used logistic regression with 1 observation per participant for this outcome. Should repeated-measure analyses be conducted instead? 4. Missing data and sensitivity analysis In this study, over a quarter of data (26%) were missed on key information such as coronary calcification. The researcher used a weight approach to adjust for the missing data and a sensitivity analysis showed that unweighted and weighted analyses had approximately equal results. Other alternatives are to conduct sensitivity analysis with Multiple Imputation (MI), Maximum Likelihood (ML), and Weighted Estimating Equation (WEE), especially when dealing with large proportion of missing data. 4

Detailed Technical Issues 1) On page 191, in first sentence in section Study sample and menthol preference, (30%) can be added after the number 144. 2) On page 191, in the sentence Before adjustment, menthol smokers were less likely to be noncurrent smokers at follow-up examinations in section Smoking cessation behavior, double negatives were used. It would be easier to understand if changing the sentence to menthol smokers were more likely to be current smokers at follow-up examinations. 3) Redundant information regarding statistical significance (both 9% CI and p-value) was presented all over the research paper. For example, on page 191, in the Results section of the abstract, it presented odds ratio [OR], 0.1;9%confidence interval [CI], 0.49-1.02; P=.06. Reference: Sidney et al 1989. Mentholated Cigarette Use among Multiphasic Examinees, 199-86 Am J Public Health. 1989 Oct;9():141-6, by Drs. Sidney S, Tekawa I, and Friedman GD.